Trial Profile
Prevention of Dabigatran-related Gastrointestinal Bleeding With Gastroprotective Agents: A Population-Based Study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Stroke; Venous thromboembolism
- Focus Adverse reactions
- 01 Dec 2015 New trial record